Sulfasalazine: A Potent Treatment for Inflammatory Bowel Disease
It is an anti-inflammatory drug used to treat inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease. It works by reducing inflammation in the …
Empowering Industries, Enlightening Minds
It is an anti-inflammatory drug used to treat inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease. It works by reducing inflammation in the …
Enrofloxacin is a broad-spectrum fluoroquinolone antibiotic used for both therapeutic and non-therapeutic purposes in veterinary medicine. Originally developed and marketed by Bayer in the 1980s, …
Sulfasalazine is an oral medication used primarily in the treatment of rheumatoid arthritis and inflammatory bowel disease. It works by suppressing the immune system’s inflammatory …
Remicade biosimilars are monoclonal antibodies used to treat various autoimmune diseases such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis, ankylosing spondylitis, and psoriatic arthritis. Remicade, …
The global Enrofloxacin Market is estimated to be valued at US$ 470.4 Mn in 2023 and is expected to exhibit a CAGR of 4.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.